Stockreport

Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ... [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Immune Medicine Revenue: $9.0 million, down 32% from a year ago. ClonoSEQ Test Volume: Increased 30% to 19,600 tests delivered. Sequencing Margin: 56% for the quart [Read more]